SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001214659-24-007806
Filing Date
2024-04-30
Accepted
2024-04-29 21:55:03
Documents
19

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 b426244posam4.htm   iXBRL POS AM 594431
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 6876
7 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
8 GRAPHIC chart.jpg GRAPHIC 82020
9 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
  Complete submission text file 0001214659-24-007806.txt   1197331

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bdrx-20240429.xsd EX-101.SCH 2924
4 XBRL DEFINITION FILE bdrx-20240429_def.xml EX-101.DEF 26950
5 XBRL LABEL FILE bdrx-20240429_lab.xml EX-101.LAB 37018
6 XBRL PRESENTATION FILE bdrx-20240429_pre.xml EX-101.PRE 25602
22 EXTRACTED XBRL INSTANCE DOCUMENT b426244posam4_htm.xml XML 6808
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-240984 | Film No.: 24893768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)